SCHEMBL4943634

SCHEMBL4943634

COc1ccc(OC)c(-c2ccc(C(=O)NC(=N)N)o2)c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.64
MAPT P10636 4/20 0.64
HPGD P15428 3/20 0.64
SLC9A1 P19634 5/20 0.63
S1PR4 O95977 5/20 0.55
ABCB1 P08183 1/20 0.49
S1PR5 Q9H228 1/20 0.48
KCNH2 Q12809 1/20 0.47
KDM4E B2RXH2 2/20 0.46
RXFP1 Q9HBX9 1/20 0.46
GAA P10253 1/20 0.44
MAPK1 P28482 1/20 0.44
HSD17B10 Q99714 1/20 0.44
NPC1 O15118 1/20 0.42
LMNA P02545 1/20 0.42
CASP3 P42574 1/20 0.42
RAB9A P51151 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
SENP7 Q9BQF6 1/20 0.42
SENP6 Q9GZR1 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4940226 0.87 SLC9A1 (0.64) ALDH1A1MAPTHPGDSLC9A1S1PR4
SCHEMBL4537674 0.87 ALDH1A1 (0.65) ALDH1A1MAPTHPGDSLC9A1S1PR4
SCHEMBL4941055 0.87 SLC9A1 (0.64) ALDH1A1MAPTHPGDSLC9A1S1PR4
SCHEMBL4943003 0.80 ALDH1A1 (0.76) ALDH1A1MAPTHPGDSLC9A1S1PR4
SCHEMBL4939604 0.80 ALDH1A1 (0.56) ALDH1A1MAPTHPGDSLC9A1ABCB1
SCHEMBL4943762 0.78 ABCB1 (0.48) ALDH1A1MAPTHPGDSLC9A1S1PR4
SCHEMBL3713569 0.78 SLC9A1 (0.61) ALDH1A1MAPTHPGDSLC9A1S1PR4
SCHEMBL4943638 0.78 SLC9A1 (1.00) ALDH1A1MAPTHPGDSLC9A1S1PR4
SCHEMBL4948227 0.77 KMT2A (0.43) ALDH1A1MAPTHPGDSLC9A1S1PR4
SCHEMBL4942546 0.77 NQO2 (0.53) ALDH1A1MAPTHPGDSLC9A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7351843-B2 Furancarbonylguanidine derivatives, their preparation and pharmaceutical compositions containing them KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2008-04-01 US claimed
US-20070299131-A1 Furancarbonylguanidine Derivatives, Their Preparation and Pharmaceutical Compositions Containing Them KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2007-12-27 US claimed
US-7351843-B2 Furancarbonylguanidine derivatives, their preparation and pharmaceutical compositions containing them KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2008-04-01 US disclosed
US-20070299131-A1 Furancarbonylguanidine Derivatives, Their Preparation and Pharmaceutical Compositions Containing Them KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2007-12-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070299131-A1 Furancarbonylguanidine Derivatives, Their Preparation and Pharmaceutical Compositions Containing Them SLC9A1, NHERF1, SLC5A1 ALDH1A1 297/4885MAPT 4846/4885HPGD 242/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.